Hematology/Oncology

Top Story

Physical activity associated with lower risks of 13 cancers

May 26, 2016

Leisure-time physical activity was associated with lower risks for 13 out of 26 cancers included in an investigation published in JAMA Internal Medicine.

Steven C. Moore, PhD, MPH, in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, and colleagues stressed physicians should counsel inactive adults regarding the associations, regardless of body size or smoking history.

In the Journals

Catheter-directed thrombolysis reduces post-thrombotic syndrome after DVT

May 26, 2016
Catheter-directed thrombolysis appeared associated with a persistent risk reduction for post-thrombotic syndrome among patients with extensive proximal deep vein…
In the JournalsPerspective

Androgen suppression benefits men with rising PSA after prostatectomy

May 26, 2016
The addition of short-term androgen suppression to salvage radiotherapy significantly extended PFS among men with rising PSA concentrations after radical prostatectomy…
Meeting News Coverage

Disparities in CRC incidence between blacks, whites may be decreasing

May 26, 2016
SAN DIEGO — Trends in colorectal cancer incidence rates and stage at diagnosis among whites and blacks indicated that racial disparities may be decreasing…
In the Journals

Deferred therapy may benefit some patients with mantle cell lymphoma

May 26, 2016
Deferring initial treatment for more than 90 days prolonged OS among certain patients with mantle cell lymphoma, according to a national cohort analysis. Patients most…
More News Headlines »
CME

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Video

VIDEO: Understanding of genetics in AML, MDS help predict prognosis, response to treatment

May 6, 2016
More »
Featured
AACR Annual Meeting

AACR Annual Meeting

CME Video

World Lung Updates: Immunotherapy in NSCLC

This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan